Discover 1 curated intelligence briefings related to this specific topic.
The rise of GLP-1 agonists isn't just a medical breakthrough; it's a commercial wrecking ball. As millions lose the 'food noise' that drives impulsive consumption, the global food market is facing a second-order crisis: the death of the Bliss Point.
